DK1126823T3 - Fremgangsmåde til fremstilling af sterilt terapeutisk acceptabelt beclometason-dipropionat - Google Patents
Fremgangsmåde til fremstilling af sterilt terapeutisk acceptabelt beclometason-dipropionatInfo
- Publication number
- DK1126823T3 DK1126823T3 DK99955895T DK99955895T DK1126823T3 DK 1126823 T3 DK1126823 T3 DK 1126823T3 DK 99955895 T DK99955895 T DK 99955895T DK 99955895 T DK99955895 T DK 99955895T DK 1126823 T3 DK1126823 T3 DK 1126823T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- sterile
- therapeutically acceptable
- beclometasone dipropionate
- directed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002364A IT1303692B1 (it) | 1998-11-03 | 1998-11-03 | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
PCT/EP1999/008176 WO2000025746A2 (en) | 1998-11-03 | 1999-10-28 | A process for the preparation of suspensions of drug particles for inhalation delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1126823T3 true DK1126823T3 (da) | 2007-05-21 |
Family
ID=11380994
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99955895T DK1126823T3 (da) | 1998-11-03 | 1999-10-28 | Fremgangsmåde til fremstilling af sterilt terapeutisk acceptabelt beclometason-dipropionat |
DK06017746.6T DK1832279T3 (en) | 1998-11-03 | 1999-10-28 | Process for preparing suspensions containing active substance particles for use by inhalation administration |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06017746.6T DK1832279T3 (en) | 1998-11-03 | 1999-10-28 | Process for preparing suspensions containing active substance particles for use by inhalation administration |
Country Status (26)
Country | Link |
---|---|
US (1) | US6464958B1 (cs) |
EP (2) | EP1126823B1 (cs) |
JP (1) | JP2002528484A (cs) |
KR (1) | KR100783096B1 (cs) |
CN (1) | CN1158997C (cs) |
AT (1) | ATE352288T1 (cs) |
AU (1) | AU762367B2 (cs) |
BR (2) | BRPI9917701B1 (cs) |
CA (2) | CA2614633C (cs) |
CY (2) | CY1107659T1 (cs) |
CZ (2) | CZ2007211A3 (cs) |
DE (1) | DE69935002T2 (cs) |
DK (2) | DK1126823T3 (cs) |
EA (1) | EA003228B1 (cs) |
ES (1) | ES2281197T3 (cs) |
HU (2) | HU226734B1 (cs) |
IT (1) | IT1303692B1 (cs) |
NO (1) | NO20012175L (cs) |
NZ (1) | NZ511305A (cs) |
PL (1) | PL195908B1 (cs) |
PT (1) | PT1126823E (cs) |
SI (1) | SI1126823T1 (cs) |
SK (2) | SK288316B6 (cs) |
TR (1) | TR200101209T2 (cs) |
WO (1) | WO2000025746A2 (cs) |
ZA (1) | ZA200103526B (cs) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69633222T2 (de) * | 1995-02-24 | 2005-09-08 | Elan Pharma International Ltd. | Nanopartikel-dispersionen enthaltende aerosole |
CZ303495B6 (cs) | 1998-11-02 | 2012-10-24 | Elan Pharma International Limited | Mnohocásticový modifikovane uvolnující prostredek a jeho použití, pevná orální dávkovací forma |
AUPQ573300A0 (en) * | 2000-02-21 | 2000-03-16 | Australian Nuclear Science & Technology Organisation | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
NZ523693A (en) * | 2000-07-10 | 2004-08-27 | Chiron Corp | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
SG98420A1 (en) * | 2000-07-13 | 2003-09-19 | Purzer Pharmaceutical Co Ltd | Method for transferring one or more active ingredients between different phase carriers |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030091513A1 (en) * | 2001-10-03 | 2003-05-15 | Mohsen Nahed M. | Method to generate water soluble or nonwater soluble in nanoparticulates directly in suspension or dispersion media |
US20030129242A1 (en) * | 2002-01-04 | 2003-07-10 | Bosch H. William | Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
DK1476201T3 (da) | 2002-02-19 | 2009-03-30 | Resolution Chemicals Ltd | Solvent-baseret sterilisering af steroider |
ITMI20020808A1 (it) * | 2002-04-17 | 2003-10-17 | Chiesi Farma Spa | Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione |
AU2003268380A1 (en) * | 2002-10-04 | 2004-05-04 | Elan Pharma International Limited | Gamma irradiation of solid nanoparticulate active agents |
ITMI20022674A1 (it) * | 2002-12-18 | 2004-06-19 | Chiesi Farma Spa | Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione. |
US20040208833A1 (en) * | 2003-02-04 | 2004-10-21 | Elan Pharma International Ltd. | Novel fluticasone formulations |
WO2004073685A1 (en) * | 2003-02-20 | 2004-09-02 | Constant Research & Development Limited | Dexamethasone-containing formulations for oral administration as well the process for manufacturing required therefor |
EP1454636A1 (en) * | 2003-03-04 | 2004-09-08 | Dompé S.P.A. | Sterilization of glucocorticoid drug particles for pulmonary delivery |
US9808471B2 (en) * | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
US7811606B2 (en) * | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
US8912174B2 (en) * | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
US7842232B2 (en) * | 2003-05-22 | 2010-11-30 | Elan Pharma International, Ltd. | Sterilization of dispersions of nanoparticulate active agents with gamma radiation |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
GB0319500D0 (en) * | 2003-08-19 | 2003-09-17 | Resolution Chemicals Ltd | Particle-size reduction apparatus,and use thereof |
ITMI20032054A1 (it) * | 2003-10-22 | 2005-04-23 | Monteres S R L | Processo per la preparazione di sospensioni farmaceutiche da inalare. |
AU2004291542A1 (en) * | 2003-11-18 | 2005-06-02 | Yansong Shan | Healthy pleasurable inhalation device |
PE20050941A1 (es) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | Suspensiones acuosas de ciclesonida para nebulizacion |
US7892483B2 (en) * | 2004-03-12 | 2011-02-22 | Cipla Limited | Sterilization process |
GB0406515D0 (en) * | 2004-03-23 | 2004-04-28 | Novartis Ag | Organic compounds |
KR101179393B1 (ko) | 2004-03-23 | 2012-09-07 | 노파르티스 아게 | 제약 조성물 |
ITMI20040795A1 (it) * | 2004-04-23 | 2004-07-23 | Eratech S R L | Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa |
GB0410995D0 (en) | 2004-05-17 | 2004-06-23 | Norton Healthcare Ltd | Heat sterilization of glucocorticosteroids |
GB0425266D0 (en) | 2004-11-16 | 2004-12-15 | Norton Healthcare Ltd | Pharmaceutical manufacturing process |
JP5324098B2 (ja) * | 2004-11-16 | 2013-10-23 | アルケルメス ファーマ アイルランド リミテッド | 注射可能なナノ粒子のオランザピン製剤 |
GB0427568D0 (en) * | 2004-12-16 | 2005-01-19 | Resolution Chemicals Ltd | Particle-size reduction apparatus, and the use thereof |
ES2388287T3 (es) | 2005-01-20 | 2012-10-11 | Eratech S.R.L. | Procedimiento para la preparación de suspensiones concentradas de fármacos y kit correspondiente |
US20090252801A1 (en) * | 2005-11-29 | 2009-10-08 | Farmbios S.P.A. | Process for the Preparation of Micronised Sterile Steroids |
KR20090031618A (ko) * | 2006-07-12 | 2009-03-26 | 엘란 코포레이션, 피엘씨 | 나노입자형 모다피닐 제제 |
AU2008334547B2 (en) * | 2007-12-13 | 2011-06-30 | Novartis Ag | Organic compounds |
BRPI1008165B1 (pt) * | 2009-05-25 | 2020-02-27 | Chiesi Farmaceutici S.P.A. | Uma combinação terapêutica compreendendo um surfactante pulmonar e um esteróide |
BR112013027391A2 (pt) | 2011-05-03 | 2017-01-17 | Chiesi Farmaceutic S P A | formulação farmacêutica, frasco e kit |
DK2704687T3 (en) | 2011-05-04 | 2015-10-05 | Chiesi Farma Spa | Topical formulation having a corticosteroid as an active ingredient |
CN104739811A (zh) * | 2015-02-27 | 2015-07-01 | 上海臣邦医药科技有限公司 | 一种糖皮质激素雾化吸入混悬液及其制备方法 |
TWI773641B (zh) * | 2015-05-08 | 2022-08-11 | 日商活效製藥股份有限公司 | 含有糖皮質類固醇(glucocorticoids)之奈米微粒子之水性懸浮液劑 |
WO2023136787A1 (en) * | 2022-01-17 | 2023-07-20 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Process for the preparation of a sterile, homogeneous suspension for inhalation by nebulization |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0416950T3 (da) * | 1989-09-08 | 1993-10-11 | Glaxo Group Ltd | Medikamenter |
US5126123A (en) * | 1990-06-28 | 1992-06-30 | Glaxo, Inc. | Aerosol drug formulations |
JPH0486921A (ja) * | 1990-07-31 | 1992-03-19 | Omron Corp | 近似推論のための知識ベース形成方法および装置 |
US5046326A (en) | 1990-10-24 | 1991-09-10 | Thermo King Corporation | Transport refrigeration system |
IT1243911B (it) * | 1990-11-19 | 1994-06-28 | Zambon Spa | Composizioni per la terapia mucolitica |
GB9202519D0 (en) * | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
IL101387A (en) * | 1992-03-26 | 1999-11-30 | Pharmos Ltd | Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets |
UY24147A1 (es) * | 1995-01-20 | 1996-02-02 | Gruenenthal Chemie | Procedimiento y dispositivo para preparar composiciones dispersables por aspersion de aerosoles |
US6135628A (en) * | 1995-10-13 | 2000-10-24 | Boehringer Ingelheim Pharmceuticals, Inc. | Method and apparatus for homogenizing aerosol formulations |
IT1286496B1 (it) * | 1996-11-20 | 1998-07-15 | Leetrim Ltd Dublin | Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria |
SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
-
1998
- 1998-11-03 IT IT1998MI002364A patent/IT1303692B1/it active
-
1999
- 1999-10-28 HU HU0104230A patent/HU226734B1/hu unknown
- 1999-10-28 EP EP99955895A patent/EP1126823B1/en not_active Expired - Lifetime
- 1999-10-28 HU HU0700446A patent/HU230121B1/hu unknown
- 1999-10-28 KR KR1020017005023A patent/KR100783096B1/ko active IP Right Grant
- 1999-10-28 CZ CZ2007-211A patent/CZ2007211A3/cs not_active IP Right Cessation
- 1999-10-28 PL PL99347908A patent/PL195908B1/pl unknown
- 1999-10-28 BR BRPI9917701A patent/BRPI9917701B1/pt not_active IP Right Cessation
- 1999-10-28 WO PCT/EP1999/008176 patent/WO2000025746A2/en active Application Filing
- 1999-10-28 SK SK94-2006A patent/SK288316B6/sk not_active IP Right Cessation
- 1999-10-28 US US09/830,884 patent/US6464958B1/en not_active Expired - Lifetime
- 1999-10-28 ES ES99955895T patent/ES2281197T3/es not_active Expired - Lifetime
- 1999-10-28 CA CA2614633A patent/CA2614633C/en not_active Expired - Lifetime
- 1999-10-28 DK DK99955895T patent/DK1126823T3/da active
- 1999-10-28 CZ CZ20011541A patent/CZ300650B6/cs not_active IP Right Cessation
- 1999-10-28 BR BRPI9915251A patent/BRPI9915251B8/pt not_active IP Right Cessation
- 1999-10-28 SK SK593-2001A patent/SK285487B6/sk not_active IP Right Cessation
- 1999-10-28 AU AU12666/00A patent/AU762367B2/en not_active Ceased
- 1999-10-28 JP JP2000579190A patent/JP2002528484A/ja active Pending
- 1999-10-28 CN CNB998129348A patent/CN1158997C/zh not_active Expired - Lifetime
- 1999-10-28 PT PT99955895T patent/PT1126823E/pt unknown
- 1999-10-28 EP EP06017746.6A patent/EP1832279B1/en not_active Expired - Lifetime
- 1999-10-28 DK DK06017746.6T patent/DK1832279T3/en active
- 1999-10-28 NZ NZ511305A patent/NZ511305A/en unknown
- 1999-10-28 AT AT99955895T patent/ATE352288T1/de active
- 1999-10-28 SI SI9930948T patent/SI1126823T1/sl unknown
- 1999-10-28 CA CA002349268A patent/CA2349268C/en not_active Expired - Lifetime
- 1999-10-28 DE DE69935002T patent/DE69935002T2/de not_active Expired - Lifetime
- 1999-10-28 TR TR2001/01209T patent/TR200101209T2/xx unknown
- 1999-10-28 EA EA200100397A patent/EA003228B1/ru not_active IP Right Cessation
-
2001
- 2001-05-02 ZA ZA200103526A patent/ZA200103526B/en unknown
- 2001-05-02 NO NO20012175A patent/NO20012175L/no not_active Application Discontinuation
-
2007
- 2007-03-29 CY CY20071100437T patent/CY1107659T1/el unknown
-
2015
- 2015-07-23 CY CY20151100651T patent/CY1116943T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1126823T3 (da) | Fremgangsmåde til fremstilling af sterilt terapeutisk acceptabelt beclometason-dipropionat | |
BRPI0409381A (pt) | formulações farmacêuticas nasais e métodos de utilizar as mesmas | |
BR9915095A (pt) | Composição farmacêutica ministrável em aerosol | |
TW200501983A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
ATE387430T1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
TW200612987A (en) | Combination treatment for non-hematologic malignancies | |
HK1104968A1 (en) | Use of immunomodulatory compounds in the manufacture of a medicament for the treatment and management of cancers and other diseases, and compositions thereof | |
MXPA05006940A (es) | Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide. | |
MA27702A1 (fr) | Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation | |
NO20001087D0 (no) | Medikament for forlengelse av muskelfunksjon eller behandling av muskelforstyrrelser eller -sykdommer | |
EA200900451A1 (ru) | Способ получения композиции эстрадиола с медленным высвобождением ( варианты ), микросферы эстрадиола и холестерина и способ для одновременной контрацепции и гормонозамещения | |
FR2651678B1 (fr) | Composition pharmaceutique a base de salmeterol et de dipropionate de beclometasone. | |
HUP0104410A2 (hu) | Ateroszklerózis megelőzésére és/vagy kezelésére szolgáló gyógyszerkészítmények | |
BR0304821A (pt) | Processo de preparação de uma suspensão estéril de partìculas de corticosteróide para administração por inalação | |
GB9918559D0 (en) | Novel pharmaceutical formulation | |
NO20044496L (no) | Torr pulver innhaleringssammensetning | |
WO2005044187A3 (en) | Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same | |
EA200500387A1 (ru) | Композиции для ингаляции с высоким содержанием лекарственных веществ | |
ATE360443T1 (de) | Sterilisierung von beclometason- arzneimittelteilchen zur anwendung in der lunge | |
DE60202299D1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten | |
LT2006062A (lt) | Elementinės sieros vaistiniai produktai, skirti su glutationo s transferazės fermentu susijusioms ligoms gydyti | |
CA2295389A1 (en) | Method of treatment of nausea, vomiting, and other disorders using estrogens |